SuchitraSundaramMD

PubMed

• 12 citations
  Aggressive Lymphoma Subtype Is A Risk Factor for Venous Thrombosis. Development of Lymphoma - Specific Venous Thrombosis Prediction Models.
  Gouri Dharmavaram, Shufen Cao, Suchitra Sundaram, Sabarish Ayyappan, Kirsten M Boughan
  American Journal of Hematology. 2020-04-20
• 236 citations
  Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
  Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna, John N. Allan, Lori A. Leslie
  Blood. 2020-09-03
• 230 citations
  Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
  Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak, Chan Yoon Cheah, John M. Pagel
  Lancet. 2021-03-06

Abstracts/Posters

• Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
  Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Patients with Refractory Peripheral T-Cell Lymphoma, Angioimmunoblastic and Other Nodal Lymphomas of T Follicular Helper-Cell Origin (OPerA)
  Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  Suchitra Sundaram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Early Complete Remission By Functional Imaging and Intensified Frontline Therapy Are Associated with an Improved Clinical Outcome in Patients with Newly Diagnosed T-Ce... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019